OUTLOOK THERAPEUTICS INC (OTLK) Stock Forecast & Price Target
OUTLOOK THERAPEUTICS INC · NASDAQ
$0.64-0.03 (-4.59%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering OUTLOOK THERAPEUTICS INC, 2 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $1.00 to $10.00 (about 10.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $4.15 sits 552% above the current $0.64. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.05 next quarter toward $-0.14 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy250%
Hold250%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to OUTLOOK THERAPEUTICS INC.
As of Sep, 2 of 4 firms rate OTLK a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
OTLK EPS & revenue forecast
EPS · NEXT QUARTER
$-0.05
Range $-0.09 – $-0.01 · 3 analysts · -77% YoY
Next period, 3 analysts expect OUTLOOK THERAPEUTICS INC to earn $-0.05 a share (range $-0.09 – $-0.01), versus $-0.22 a year earlier. Full-year consensus is $-0.42, growing to $-0.14 the year after.
REVENUE · NEXT QUARTER
$5.3M
Range $1.3M – $8.9M · 3 analysts · -539% YoY
Revenue is expected to reach $5.3M (range $1.3M – $8.9M), -539.1% year-over-year. Full-year consensus is $824.0K, rising to $41.6M next year.
Top analysts covering OUTLOOK THERAPEUTICS INC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OTLK.
#1
Daniil Gataulin
Chardan Capital · Rank #22
Hold
$1.00+57.1% to target
Overall win rate
58%
+ Follow
#2
Douglas Tsao
HC Wainwright & Co. · Rank #248
Hold
$1.60+151.4% to target
Overall win rate
35%
+ Follow
#3
Edward Woo
Ascendiant Capital · Rank #430
Buy
$10.00+1471.3% to target
Overall win rate
26%
+ Follow
#4
Julian Harrison
BTIG
Buy
$4.00+528.5% to target
Coverage
—
+ Follow
#5
EH
Eddie Hickman
Guggenheim
Hold
No targeton OTLK
Coverage
—
+ Follow
OTLK stock forecast FAQ
What is OTLK's average 12-month price target?+
The 4 analysts with a live target average $4.15 for OUTLOOK THERAPEUTICS INC over the next 12 months, ranging from a $10.00 high to a $1.00 low.
Is OTLK stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 2 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for OTLK?+
The Street-high target is $10.00 (Ascendiant Capital), and the Street-low is $1.00 (Chardan Capital). The average of all 4 active targets is $4.15.
How many Wall Street analysts cover OTLK?+
4 analysts have an active rating on OUTLOOK THERAPEUTICS INC, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering OTLK?+
Among analysts who currently cover OTLK, Daniil Gataulin of Chardan Capital has the strongest overall Quantellect track record (Rank #22). Their current call is Hold with a $1.00 target.
What is OUTLOOK THERAPEUTICS INC's projected EPS for next quarter?+
The consensus estimate is $-0.05 per share (range $-0.09 – $-0.01) across 3 analysts. Full-year EPS is projected at $-0.42, rising to $-0.14 the following year.
How much revenue is OUTLOOK THERAPEUTICS INC expected to report next quarter?+
Consensus revenue is $5.3M (range $1.3M – $8.9M). Full-year revenue is projected at $824.0K, growing to $41.6M next year.
Have analysts been upgrading or downgrading OTLK lately?+
As of Sep, 2 of 4 firms rate OTLK a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OTLK calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
